Supporting the role of SCD-1 in the development of dyslipidemia and atherosclerosis (at least in an animal model of OSA) is the fact that mice lacking functional SCD-1 have less dyslipidemia and atherosclerosis [44, 45]. This evidence concerns the gene SCD and metabolic syndrome.